The global market for Parkinson's Disease (PD) Drugs was valued at US$ 5987 million in the year 2024 and is projected to reach a revised size of US$ 8005 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Parkinson's Disease (PD) Drugs Market

Most people with Parkinson"s disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.

Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease (PD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease (PD) Drugs.

The Parkinson's Disease (PD) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson's Disease (PD) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinson's Disease (PD) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Parkinson's Disease (PD) Drugs Market Report

Report Metric	Details
Report Name	Parkinson's Disease (PD) Drugs Market
Accounted market size in year	US$ 5987 million
Forecasted market size in 2031	US$ 8005 million
CAGR	4.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Dopamine Agonist Monoamine Oxidase Inhibitors Acetylcholinesterase Inhibitors Glutamate Inhibitors
Segment by Application	Hospital Family
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, AbbVie, Abital Pharma, Addex Therapeutics, Biogen, Eisai, Eli Lilly, F. Hoffmann-La Roche, H. Lundbeck, Impax Laboratories, Kyowa Hakko Kirin, Otsuka Pharmaceutical, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Parkinson's Disease (PD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Parkinson's Disease (PD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinson's Disease (PD) Drugs Market growing?

Ans: The Parkinson's Disease (PD) Drugs Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Parkinson's Disease (PD) Drugs Market size in 2031?

Ans: The Parkinson's Disease (PD) Drugs Market size in 2031 will be US$ 8005 million.

Who are the main players in the Parkinson's Disease (PD) Drugs Market report?

Ans: The main players in the Parkinson's Disease (PD) Drugs Market are Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, AbbVie, Abital Pharma, Addex Therapeutics, Biogen, Eisai, Eli Lilly, F. Hoffmann-La Roche, H. Lundbeck, Impax Laboratories, Kyowa Hakko Kirin, Otsuka Pharmaceutical, Pfizer

What are the Application segmentation covered in the Parkinson's Disease (PD) Drugs Market report?

Ans: The Applications covered in the Parkinson's Disease (PD) Drugs Market report are Hospital, Family

What are the Type segmentation covered in the Parkinson's Disease (PD) Drugs Market report?

Ans: The Types covered in the Parkinson's Disease (PD) Drugs Market report are Dopamine Agonist, Monoamine Oxidase Inhibitors, Acetylcholinesterase Inhibitors, Glutamate Inhibitors

1 Parkinson's Disease (PD) Drugs Market Overview

1.1 Product Definition

1.2 Parkinson's Disease (PD) Drugs by Type

1.2.1 Global Parkinson's Disease (PD) Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Dopamine Agonist

1.2.3 Monoamine Oxidase Inhibitors

1.2.4 Acetylcholinesterase Inhibitors

1.2.5 Glutamate Inhibitors

1.3 Parkinson's Disease (PD) Drugs by Application

1.3.1 Global Parkinson's Disease (PD) Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Family

1.4 Global Parkinson's Disease (PD) Drugs Market Size Estimates and Forecasts

1.4.1 Global Parkinson's Disease (PD) Drugs Revenue 2020-2031

1.4.2 Global Parkinson's Disease (PD) Drugs Sales 2020-2031

1.4.3 Global Parkinson's Disease (PD) Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Parkinson's Disease (PD) Drugs Market Competition by Manufacturers

2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Parkinson's Disease (PD) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Product Type & Application

2.7 Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Date of Enter into This Industry

2.8 Global Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends

2.8.1 Global Parkinson's Disease (PD) Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue

2.8.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Parkinson's Disease (PD) Drugs Market Scenario by Region

3.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Parkinson's Disease (PD) Drugs Sales by Region: 2020-2031

3.2.1 Global Parkinson's Disease (PD) Drugs Sales by Region: 2020-2025

3.2.2 Global Parkinson's Disease (PD) Drugs Sales by Region: 2026-2031

3.3 Global Parkinson's Disease (PD) Drugs Revenue by Region: 2020-2031

3.3.1 Global Parkinson's Disease (PD) Drugs Revenue by Region: 2020-2025

3.3.2 Global Parkinson's Disease (PD) Drugs Revenue by Region: 2026-2031

3.4 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country

3.4.1 North America Parkinson's Disease (PD) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Parkinson's Disease (PD) Drugs Sales by Country (2020-2031)

3.4.3 North America Parkinson's Disease (PD) Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country

3.5.1 Europe Parkinson's Disease (PD) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Parkinson's Disease (PD) Drugs Sales by Country (2020-2031)

3.5.3 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country

3.7.1 Latin America Parkinson's Disease (PD) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Parkinson's Disease (PD) Drugs Sales by Country (2020-2031)

3.7.3 Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2020-2031)

4.1.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2020-2025)

4.1.2 Global Parkinson's Disease (PD) Drugs Sales by Type (2026-2031)

4.1.3 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2031)

4.2 Global Parkinson's Disease (PD) Drugs Revenue by Type (2020-2031)

4.2.1 Global Parkinson's Disease (PD) Drugs Revenue by Type (2020-2025)

4.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Type (2026-2031)

4.2.3 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Parkinson's Disease (PD) Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Parkinson's Disease (PD) Drugs Sales by Application (2020-2031)

5.1.1 Global Parkinson's Disease (PD) Drugs Sales by Application (2020-2025)

5.1.2 Global Parkinson's Disease (PD) Drugs Sales by Application (2026-2031)

5.1.3 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2031)

5.2 Global Parkinson's Disease (PD) Drugs Revenue by Application (2020-2031)

5.2.1 Global Parkinson's Disease (PD) Drugs Revenue by Application (2020-2025)

5.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Application (2026-2031)

5.2.3 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Parkinson's Disease (PD) Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Company Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis Parkinson's Disease (PD) Drugs Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Teva Pharmaceutical Industries

6.4.1 Teva Pharmaceutical Industries Company Information

6.4.2 Teva Pharmaceutical Industries Description and Business Overview

6.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Portfolio

6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.5 AbbVie

6.5.1 AbbVie Company Information

6.5.2 AbbVie Description and Business Overview

6.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AbbVie Parkinson's Disease (PD) Drugs Product Portfolio

6.5.5 AbbVie Recent Developments/Updates

6.6 Abital Pharma

6.6.1 Abital Pharma Company Information

6.6.2 Abital Pharma Description and Business Overview

6.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Product Portfolio

6.6.5 Abital Pharma Recent Developments/Updates

6.7 Addex Therapeutics

6.7.1 Addex Therapeutics Company Information

6.7.2 Addex Therapeutics Description and Business Overview

6.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Portfolio

6.7.5 Addex Therapeutics Recent Developments/Updates

6.8 Biogen

6.8.1 Biogen Company Information

6.8.2 Biogen Description and Business Overview

6.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biogen Parkinson's Disease (PD) Drugs Product Portfolio

6.8.5 Biogen Recent Developments/Updates

6.9 Eisai

6.9.1 Eisai Company Information

6.9.2 Eisai Description and Business Overview

6.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Eisai Parkinson's Disease (PD) Drugs Product Portfolio

6.9.5 Eisai Recent Developments/Updates

6.10 Eli Lilly

6.10.1 Eli Lilly Company Information

6.10.2 Eli Lilly Description and Business Overview

6.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Product Portfolio

6.10.5 Eli Lilly Recent Developments/Updates

6.11 F. Hoffmann-La Roche

6.11.1 F. Hoffmann-La Roche Company Information

6.11.2 F. Hoffmann-La Roche Description and Business Overview

6.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Portfolio

6.11.5 F. Hoffmann-La Roche Recent Developments/Updates

6.12 H. Lundbeck

6.12.1 H. Lundbeck Company Information

6.12.2 H. Lundbeck Description and Business Overview

6.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 H. Lundbeck Parkinson's Disease (PD) Drugs Product Portfolio

6.12.5 H. Lundbeck Recent Developments/Updates

6.13 Impax Laboratories

6.13.1 Impax Laboratories Company Information

6.13.2 Impax Laboratories Description and Business Overview

6.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Impax Laboratories Parkinson's Disease (PD) Drugs Product Portfolio

6.13.5 Impax Laboratories Recent Developments/Updates

6.14 Kyowa Hakko Kirin

6.14.1 Kyowa Hakko Kirin Company Information

6.14.2 Kyowa Hakko Kirin Description and Business Overview

6.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Portfolio

6.14.5 Kyowa Hakko Kirin Recent Developments/Updates

6.15 Otsuka Pharmaceutical

6.15.1 Otsuka Pharmaceutical Company Information

6.15.2 Otsuka Pharmaceutical Description and Business Overview

6.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Portfolio

6.15.5 Otsuka Pharmaceutical Recent Developments/Updates

6.16 Pfizer

6.16.1 Pfizer Company Information

6.16.2 Pfizer Description and Business Overview

6.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Pfizer Parkinson's Disease (PD) Drugs Product Portfolio

6.16.5 Pfizer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis

7.2 Parkinson's Disease (PD) Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Parkinson's Disease (PD) Drugs Production Mode & Process Analysis

7.4 Parkinson's Disease (PD) Drugs Sales and Marketing

7.4.1 Parkinson's Disease (PD) Drugs Sales Channels

7.4.2 Parkinson's Disease (PD) Drugs Distributors

7.5 Parkinson's Disease (PD) Drugs Customer Analysis

8 Parkinson's Disease (PD) Drugs Market Dynamics

8.1 Parkinson's Disease (PD) Drugs Industry Trends

8.2 Parkinson's Disease (PD) Drugs Market Drivers

8.3 Parkinson's Disease (PD) Drugs Market Challenges

8.4 Parkinson's Disease (PD) Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim

GlaxoSmithKline PLC

Novartis

Teva Pharmaceutical Industries

Otsuka Pharmaceutical

Pfizer Inc

List of Tables

Table 1. Global Parkinson's Disease (PD) Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Parkinson's Disease (PD) Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Parkinson's Disease (PD) Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Parkinson's Disease (PD) Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Parkinson's Disease (PD) Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Parkinson's Disease (PD) Drugs Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Parkinson's Disease (PD) Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Parkinson's Disease (PD) Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Parkinson's Disease (PD) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Parkinson's Disease (PD) Drugs Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Parkinson's Disease (PD) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Parkinson's Disease (PD) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Parkinson's Disease (PD) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Parkinson's Disease (PD) Drugs Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Parkinson's Disease (PD) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2020-2025)

Table 51. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2026-2031)

Table 52. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2020-2025)

Table 61. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2026-2031)

Table 62. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2026-2031)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Novartis Parkinson's Disease (PD) Drugs Product

Table 84. Novartis Recent Developments/Updates

Table 85. Teva Pharmaceutical Industries Company Information

Table 86. Teva Pharmaceutical Industries Description and Business Overview

Table 87. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product

Table 89. Teva Pharmaceutical Industries Recent Developments/Updates

Table 90. AbbVie Company Information

Table 91. AbbVie Description and Business Overview

Table 92. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. AbbVie Parkinson's Disease (PD) Drugs Product

Table 94. AbbVie Recent Developments/Updates

Table 95. Abital Pharma Company Information

Table 96. Abital Pharma Description and Business Overview

Table 97. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Abital Pharma Parkinson's Disease (PD) Drugs Product

Table 99. Abital Pharma Recent Developments/Updates

Table 100. Addex Therapeutics Company Information

Table 101. Addex Therapeutics Description and Business Overview

Table 102. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Addex Therapeutics Parkinson's Disease (PD) Drugs Product

Table 104. Addex Therapeutics Recent Developments/Updates

Table 105. Biogen Company Information

Table 106. Biogen Description and Business Overview

Table 107. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Biogen Parkinson's Disease (PD) Drugs Product

Table 109. Biogen Recent Developments/Updates

Table 110. Eisai Company Information

Table 111. Eisai Description and Business Overview

Table 112. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Eisai Parkinson's Disease (PD) Drugs Product

Table 114. Eisai Recent Developments/Updates

Table 115. Eli Lilly Company Information

Table 116. Eli Lilly Description and Business Overview

Table 117. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Eli Lilly Parkinson's Disease (PD) Drugs Product

Table 119. Eli Lilly Recent Developments/Updates

Table 120. F. Hoffmann-La Roche Company Information

Table 121. F. Hoffmann-La Roche Description and Business Overview

Table 122. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product

Table 124. F. Hoffmann-La Roche Recent Developments/Updates

Table 125. H. Lundbeck Company Information

Table 126. H. Lundbeck Description and Business Overview

Table 127. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. H. Lundbeck Parkinson's Disease (PD) Drugs Product

Table 129. H. Lundbeck Recent Developments/Updates

Table 130. Impax Laboratories Company Information

Table 131. Impax Laboratories Description and Business Overview

Table 132. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 133. Impax Laboratories Parkinson's Disease (PD) Drugs Product

Table 134. Impax Laboratories Recent Developments/Updates

Table 135. Kyowa Hakko Kirin Company Information

Table 136. Kyowa Hakko Kirin Description and Business Overview

Table 137. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 138. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product

Table 139. Kyowa Hakko Kirin Recent Developments/Updates

Table 140. Otsuka Pharmaceutical Company Information

Table 141. Otsuka Pharmaceutical Description and Business Overview

Table 142. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 143. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product

Table 144. Otsuka Pharmaceutical Recent Developments/Updates

Table 145. Pfizer Company Information

Table 146. Pfizer Description and Business Overview

Table 147. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 148. Pfizer Parkinson's Disease (PD) Drugs Product

Table 149. Pfizer Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Parkinson's Disease (PD) Drugs Distributors List

Table 153. Parkinson's Disease (PD) Drugs Customers List

Table 154. Parkinson's Disease (PD) Drugs Market Trends

Table 155. Parkinson's Disease (PD) Drugs Market Drivers

Table 156. Parkinson's Disease (PD) Drugs Market Challenges

Table 157. Parkinson's Disease (PD) Drugs Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Parkinson's Disease (PD) Drugs

Figure 2. Global Parkinson's Disease (PD) Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Parkinson's Disease (PD) Drugs Market Share by Type: 2024 & 2031

Figure 4. Dopamine Agonist Product Picture

Figure 5. Monoamine Oxidase Inhibitors Product Picture

Figure 6. Acetylcholinesterase Inhibitors Product Picture

Figure 7. Glutamate Inhibitors Product Picture

Figure 8. Global Parkinson's Disease (PD) Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Parkinson's Disease (PD) Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Family

Figure 12. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Parkinson's Disease (PD) Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Parkinson's Disease (PD) Drugs Sales (2020-2031) & (K Pcs)

Figure 15. Global Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) & (2020-2031)

Figure 16. Parkinson's Disease (PD) Drugs Report Years Considered

Figure 17. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players: Market Share by Revenue in Parkinson's Disease (PD) Drugs in 2024

Figure 20. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2020-2031)

Figure 46. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Parkinson's Disease (PD) Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2031)

Figure 56. Global Revenue Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2031)

Figure 57. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2020-2031)

Figure 58. Global Sales Market Share of Parkinson's Disease (PD) Drugs by Application (2020-2031)

Figure 59. Global Revenue Market Share of Parkinson's Disease (PD) Drugs by Application (2020-2031)

Figure 60. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2020-2031)

Figure 61. Parkinson's Disease (PD) Drugs Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Levodopa Tablets Market Research Report 2024

Global Parkinson s Disease Therapeutics Market Research Report 2025

Global Anticholinergic Drugs For PD Market Research Report 2025

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Anti Parkinson s Disease Drugs Market Research Report 2024

Global Carbidopa Levodopa Tablets Market Research Report 2025

Global Compound Levodopa Market Research Report 2025

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Levodopa Market Insights Forecast to 2030

Global Oral Medications for Parkinson s Disease Market Research Report 2024

Global Carbidopa and Levodopa Sustained release Tablets Market Research Report 2024

Global Oral Parkinson s Disease Medications Market Research Report 2024

Global Targeted Drugs for Parkinson s Disease Market Research Report 2024

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Global Parkinson Treatment Drug Market Research Report 2025

Global Carbidopa and Levodopa API Market Research Report 2025

Global Parkinson s Disease Monitoring Device Market Research Report 2024

Global Oral Antiparkinsonian Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions